Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Dr A.H. Heineken Prize for Medicine 2002 (USD 150,000) for Dennis J. Selkoe

Dr A.H. Heineken Prize for Medicine 2002 (USD 150,000) for Dennis J. Selkoe

April 15, 2002

The Royal Netherlands Academy of Arts and Sciences
has awarded the
Dr A.H. Heineken Prize for Medicine 2002 (USD 150,000) to
Professor Dennis J. Selkoe, M.D.
Harvard Medical School, Boston, MA, United States
‘for his invaluable contribution to the development of the molecular study of diseases
of the brain, in particular Alzheimer’s disease’.

The subject
When the brains of Alzheimer’s patients are examined, they are found to contain ‘plaques’, made up largely of ‘amyloid beta’ proteins. For Dennis Selkoe, this formed the starting point for his research at the end of the 1970s. By applying methods drawn from biochemistry and molecular biology he has slowly but surely, and with a great deal of patience, managed to unravel the molecular components of the puzzle which is the complex disorder known as Alzheimer’s disease. What happens in the brain cells? Which substances play a role? What comes first, what is a consequence of what? Progress in finding answers to these questions has now reached the stage where the first patients are currently taking part in a trial with drugs intended to delay or prevent the disease. The social importance of this development is difficult to overestimate.
In addition, however, Selkoe’s work has led to unexpected insights into the functioning of membrane proteins which have much wider implications for biology. Results are now being achieved thanks to scientists’ better understanding of the ageing processes in the brain and of the onset and progression of Parkinson’s disease.




The Prize-winner
Dennis Selkoe was born in New York in 1943. He obtained his Master’s Degree at the University of Virginia School of Medicine in 1969, and from 1975 he was attached to Harvard Medical School in Boston, where he became Professor of Neurology in 1990. In 2000 Selkoe was made ‘Vincent and Stella Coates Professor of Neurological Diseases’, also at Harvard Medical School. He currently works as a neurologist in the Brigham and Women’s Hospital and Massachusetts General Hospital.
Selkoe enjoys an international reputation among his professional colleagues as the best researcher in the field of molecular pathogenesis of Alzheimer’s disease. He is a member of several editorial committees of scientific journals dealing with neurological topics, such as the Annual Review of Neuroscience and the American Journal of Alzheimer’s Disease. His scientific articles in Nature, Annual Review of Cell Biology, Annual Review of Neuroscience, Cell and Neuron are highly influential. It was therefore no surprise when Selkoe appeared at number 14 in the list of the ‘Best Brains of the Brain Decade’, which was drawn up by Science Watch on the basis of the 200 most-cited articles on neuroscience in the ten years between 1989 and 1998.
Selkoe has to date received a great many distinctions, including an honorary doctorate from the University of Harvard, the ‘Mathilde Solowey Award in the Neurosciences’ from the Foundation for Advanced Education in the Sciences (NIH), the Boerhaave medal from the University of Leiden, and the ‘Pioneer Award’ from the Alzheimer’s Association in the United States.
More information on Dennis Selkoe can be found on the following website: http://www.hms.harvard.edu/dms/neuroscience/fac_selkoe.html


The Prize
The Dr A.H. Heineken Prize for Medicine has been awarded since 1989. Previous Prize-winners have included Luc Montagnier, David de Wied, Barry Marshall and Eric Kandel. The latter was one of the winners of the Nobel Prize for Medicine in 2000. Further background information about the Prize can be found on the website of the Royal Netherlands Academy of Arts and Sciences: http://www.knaw.nl/heinekenprizes.

The awards ceremony
The Heineken Prizes are presented every two years during a special session of the Academy. This year’s awards ceremony will take place on Tuesday, 24 September 2002 in the Beurs van Berlage building in Amsterdam.

Royal Netherlands Academy of Arts and Sciences (KNAW)



Related Alzheimer Disease Current Events and Alzheimer Disease News Articles Alzheimer Disease Current Events and Alzheimer Disease News RSS Alzheimer Disease Current Events and Alzheimer Disease News RSS
Delirium in hospitalized adults: Situation critical, no relief available
Every year as many as seven million adults in the United States experience delirium during hospitalization.

New data demonstrate potential for early detection of Alzheimer's disease
Data published in the June issue of the Journal of Alzheimer's Disease demonstrated that minimally-invasive biospectroscopy was able to identify changes in oxidative stress (OS) levels in blood plasma, which may prove to be a useful biomarker in the early detection of Alzheimer's disease.

Another McGill/JGH breakthrough opens door to early Alzheimer's diagnosis
A new diagnostic technique which may greatly simplify the detection of Alzheimer's disease has been discovered by researchers at McGill University and the affiliated Lady Davis Institute for Medical Research at Montreal's Jewish General Hospital (JGH).

Measuring brain atrophy in patients with mild cognitive impairment
Scientists at the University of California, San Diego School of Medicine have shown that a fully automated procedure called Volumetric MRI - which measures the "memory centers" of the brain and compares them to expected size - is effective in predicting the progression from mild cognitive impairment (MCI) to Alzheimer's disease.

Commonly used medications may produce cognitive impairment in older adults
Many drugs commonly prescribed to older adults for a variety of common medical conditions including allergies, hypertension, asthma, and cardiovascular disease appear to negatively affect the aging brain causing immediate but possibly reversible cognitive impairment, including delirium, in older adults.

Commonly used ulcer drugs may offer treatment potential in Alzheimer's disease
In a new study, published in the May issue of Elsevier's Experimental Neurology, scientists at the University of British Columbia have discovered that drugs commonly used to treat ulcers have significant neuroprotective properties, which appear to be enhanced when used in combination with ibuprofen, a widely used anti-inflammatory drug.

New test for mysterious metabolic diseases developed at Stanford/Packard
Scientists at Stanford University School of Medicine have devised a much-needed way to monitor and find treatments for a mysterious and devastating group of metabolic diseases that arise from mutations in cells' fuel-burning mechanism.

Recalibrating 'fight or flight'
A Canadian/U.S. research team has reported a novel approach to stimulating recovery from chronic stress disorders. Details of the therapeutic model, which exploits the natural dynamics of the body's "fight or flight" system, are published January 23 in the open-access journal PLoS Computational Biology

Vitamin B does not slow cognitive decline in Alzheimer's
A clinical trial led by Paul S. Aisen, M.D., professor of neurosciences at the University of California, San Diego School of Medicine, showed that high-dose vitamin B supplements did not slow the rate of cognitive decline in patients with mild to moderate Alzheimer disease.

Protecting patient privacy the new fashioned way
Protecting patient privacy has been recognized as the duty of health-care providers for about as long as doctors have seen patients. In 1996 that duty became a legal obligation when Congress passed the Health Insurance Portability and Accountability Act.
More Alzheimer Disease Current Events and Alzheimer Disease News Articles
A Caregiver's Guide to Alzheimer's Disease: 300 Tips for Making Life Easier

A Caregiver's Guide to Alzheimer's Disease: 300 Tips for Making Life Easier
by Patricia R. Callone (Editor)

Written for patients, their families, and caregivers, the practical information here will help readers understand what is physically happening to the brain so they can empower their own special skills and talents throughout the disease process. The book is divided into three sections that correspond to the progression of Alzheimer’s, and the unique challenges encountered at each stage.

*Section A: The four stages of Alzheimer's with hundreds of practical tips for coping at each level

*Section B: Q&A for caregivers, including legal and financial issues, medication, helping children understand, handling the holidays and more.

*Section C: Resources and websites.

This is an essential book for all those who want to focus on the capabilities that...

Learning to Speak Alzheimer's: A Groundbreaking Approach for Everyone Dealing with the Disease

Learning to Speak Alzheimer's: A Groundbreaking Approach for Everyone Dealing with the Disease
by Joanne Koenig Coste (Author), Robert Butler (Foreword)

More than four million Americans suffer from Alzheimer’s, and as many as twenty million have close relatives or friends with the disease. Revolutionizing the way we perceive and live with Alzheimer’s, Joanne Koenig Coste offers a practical approach to the emotional well-being of both patients and caregivers that emphasizes relating to patients in their own reality. Her accessible and comprehensive method, which she calls habilitation, works to enhance communication between carepartners and patients and has proven successful with thousands of people living with dementia. Learning to Speak Alzheimer’s also offers hundreds of practical tips, including how to · cope with the diagnosis and adjust to the disease’s progression · help the patient talk about the illness · face the...

Alzheimer's Disease: Facing the Facts

Alzheimer's Disease: Facing the Facts
Starring: n/a
Directed By: n/a

Studio: Wgbh Wholesale Release Date: 03/17/2009 Run time: 56 minutes

The Alzheimer's Action Plan: What You Need to Know--and What You Can Do--about Memory Problems, from Prevention to Early Intervention and Care

The Alzheimer's Action Plan: What You Need to Know--and What You Can Do--about Memory Problems, from Prevention to Early Intervention and Care
by P. Murali Doraiswamy M.D. (Author), Lisa P. Gwyther M.S.W. (Author), Tina Adler (Author)

What would you do if your mother was having memory problems?

Five million Americans have Alzheimer’s disease, with a new diagnosis being made every seventy-two seconds, with millions more at risk. Although experts agree that early diagnosis and treatment are essential, families don’t know where to turn for authoritative, state-of-the-art advice and answers to all of their questions.

Now, combining the insights of a world-class physician and an award-winning social worker, this ground-breaking book tells you everything you need to know, including:

The best tests to determine if this is—or is not—Alzheimer’s disease...

  Journal of Alzheimers Disease
by Ios Press



My Journey into Alzheimer's Disease

My Journey into Alzheimer's Disease
by Robert Davis (Author)

A book of encouragement of how one man of faith faced the oncoming darkness of Alzheimer's disease. In a powerful story of courage and faith, Davis shows how God gives strength and grace.

FlameEz-Memory, 60 Capsules/Bottle

FlameEz-Memory, 60 Capsules/Bottle
by FlameEz

Memory loss is caused by a condition in which cells of the brain are damaged or lost. Dementia and Alzheimer's disease are the common disorders that cause memory loss. Studies have shown that neuron damage begins long before an individual experiences any symptoms and the symptoms are only recognized when many cells have died and the brains can no longer function properly. Unlike many cells in the rest of the body, neurons are not readily regenerated. For this reason, memory loss is a progressive condition that only gets worse, there is no coming back from it. Advanced science has shown critical role of inflammation in Alzheimer's and neurodegenerative diseases. When the brain is injured or infected, cells in the brain called microglia produce inflammatory cytokines. Normally, this...

Alzheimer's Disease & Other Dementias [VHS]

Alzheimer's Disease & Other Dementias [VHS]
Directed By: Mark Julian Campbell



Part 1: Alzheimer's and Related Dementia

Part 1: Alzheimer's and Related Dementia
Directed By: Matt Connolly
Also With: H. Diane Connolly (Producer)



Caring for the Caregiver -- A Guide to Living with Alzheimer's Disease

Caring for the Caregiver -- A Guide to Living with Alzheimer's Disease

171 pages

© 2009 BrightSurf.com